H.R. 478 · 116th Congress
Safe and Affordable Drugs from Canada Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
PingreeSponsor15 cosponsors · 12 D, 3 R
R
Herrera Beutler
JG
D
Golden
EC
D
Case
SC
D
Cohen
LD
D
Doggett
JG
D
Garamendi
DL
D
Lipinski
PW
D
Welch
AC
D
Craig
MR
D
Rose
RK
D
Khanna
TR
D
Ryan
ES
D
Slotkin
DJ
R
Joyce
TT
R
Tiffany1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug
What it does: CRS summary · Introduced in House · Jan 10, 2019
Safe and Affordable Drugs from Canada Act of 2019
This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA.
Under the bill, certain drugs may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Safe and Affordable Drugs from Canada Act of 2019
Latest action (Jan 25, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jan 10, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.